🔎 Trials Near Me

ホーム › バーキットリンパ腫 › ネバダ州

ネバダ州におけるバーキットリンパ腫の臨床試験

ネバダ州内の拠点で、バーキットリンパ腫に関する6件の研究が参加者を募集しています。

ネバダ州内の都市

公式研究テキスト（英語）

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
被験者募集中第2相
366 Days – 46 Years · 全性別 · 2026/10/02更新 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

  • OptumCare Cancer Care at Charleston, Las Vegas
  • OptumCare Cancer Care at Fort Apache, Las Vegas
被験者募集中第3相
18歳〜39歳 · 全性別 · 2026/10/02更新 · NCT03150693

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • OptumCare Cancer Care at Charleston, Las Vegas
  • OptumCare Cancer Care at Fort Apache, Las Vegas
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
被験者募集中第2相
365 Days · 全性別 · 2026/09/25更新 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
  • Summerlin Hospital Medical Center, Las Vegas
  • Renown Regional Medical Center, Reno
被験者募集中第2相
1歳〜30歳 · 全性別 · 2026/09/01更新 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
  • Summerlin Hospital Medical Center, Las Vegas
  • Renown Regional Medical Center, Reno
被験者募集中第3相
365 Days – 25 Years · 全性別 · 2026/08/25更新 · NCT03959085

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。